Literature DB >> 6983938

The immunological profile of mycosis fungoides.

J R Jensen, K Thestrup-Pedersen, S Ahrons, H Zachariae.   

Abstract

The immune reactivity of 25 patients with mycosis fungoides was studied twice with a 6 month interval using a panel of T lymphocyte surface markers and functional tests. Patients with clinically inactive disease (stage I + II) had normal T lymphocyte biology. Patients with clinically active disease (stage II-IV) had T lymphopenia, alterations in T cell subpopulations (T gamma and T mu) and a reduced lymphocyte reactivity in vitro following mitogen (PHA, Con A, PWM) and antigen (PPD) stimulation. They also had a reduced secretion of immunoglobulin in vitro after PWM stimulation, apparently due to the alterations in their T lymphocyte subpopulations. The observed changes in the peripheral blood T lymphocyte population and the in vitro function of lymphocytes were not shared by lymphocytes from histologically affected lymph nodes. The natural killer cell activity in blood lymphocytes was found to be normal in all patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6983938      PMCID: PMC1536693     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

Review 1.  Current problems in mycosis fungoides and Sézary syndrome.

Authors:  R K Winkelmann; W A Caro
Journal:  Annu Rev Med       Date:  1977       Impact factor: 13.739

2.  Human spontaneous killer cells selective for tumour-derived target cells.

Authors:  M Jondal; C Spine; S Targan
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

3.  Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.

Authors:  E J Van Scott; J D Kalmanson
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

4.  Mycosis fungoides: the pathology of extracutaneous involvement.

Authors:  H Rappaport; L B Thomas
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

5.  Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studies.

Authors:  R L Edelson; C H Kirkpatrick; E M Shevach; P S Schein; R W Smith; I Green; M Lutzner
Journal:  Ann Intern Med       Date:  1974-06       Impact factor: 25.391

6.  Mycosis fungoides--a disease of antigen persistence.

Authors:  R S Tan; C M Butterworth; H McLaughlin; S Malka; P D Samman
Journal:  Br J Dermatol       Date:  1974-12       Impact factor: 9.302

7.  Mycosis fungoides. Survival, prognostic features, response to therapy, and autopsy findings.

Authors:  E H Epstein; D L Levin; J D Croft; M A Lutzner
Journal:  Medicine (Baltimore)       Date:  1972-01       Impact factor: 1.889

8.  Lymphocyte abnormalities in mycosis fungoides.

Authors:  R MacKie; F R Sless; R Cochran; M De Sousa
Journal:  Br J Dermatol       Date:  1976-02       Impact factor: 9.302

9.  Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness.

Authors:  L Moretta; M Ferrarini; M C Mingari; A Moretta; S R Webb
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

10.  The Sézary syndrome: a malignant proliferation of helper T cells.

Authors:  S Broder; R L Edelson; M A Lutzner; D L Nelson; R P MacDermott; M E Durm; C K Goldman; B D Meade; T A Waldmann
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

View more
  4 in total

1.  Normal peripheral-blood lymphocyte cAMP and cGMP resting levels in untreated patients with mycosis fungoides.

Authors:  A Aleksijevic; P Caussade; J M Lang; J C Stoclet; E Grosshans; S Mayer
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

2.  Etretinate therapy and immune reactivity.

Authors:  J R Jensen; M El'Ramley; T Herlin; K Kragballe; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

3.  Natural and concanavalin A-induced cytotoxic activity towards continuously growing B lymphocytes derived from patients with cutaneous T-cell lymphoma.

Authors:  J R Jensen; K Kaltoft; S Bisballe; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

4.  Stage-related decrease in natural killer cell activity in untreated patients with mycosis fungoides.

Authors:  S Levy; J L Tempé; P Caussade; A Aleksijevic; E Grosshans; S Mayer; J M Lang
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.